Our maintenance dose is listed in the NICE Guidelines with neurological involvement at two monthly intervals and without at three monthly intervals
There is no robust evidence that sublingual preparations offer a clinically meaningful advantage over standard oral tablets at equivalent doses
It is not a drug, food, or cosmetic, and must not be misbranded, misused, or mislabeled as such
Yes, the location of the injection is crucial for proper absorption
However, every drug carries some potential side effects and the same is true for cyanocobalamin also
Published Research on 5-Amino-1MQ Foundational DIO Mouse Study Neelakantan et al., Biochemical Pharmacology (2018) This paper introduced 5-Amino-1MQ as a selective and membrane-permeable small molecule inhibitor of NNMT and tested it in 3T3-L1 adipocytes and in male C57BL/6J mice maintained on a high-fat diet